Drug Policies

Ontario’s public drug programs has argued that funding treatments abroad could discourage manufacturers from participating in Canada’s drug review process.

The province says the change will improve its data on naloxone access, but RxA warns the new requirement could discourage some people from getting a potentially life-saving kit.

A man in his 60s tells you he's stopping his ramipril. He saw a video saying magnesium and beet juice could do the same job, naturally. He feels fine. He's felt fine the whole time he's been taking it, which is exactly why the video sounded reasonable.

The policy leaves out women for now and faces questions from medical experts about the need and efficacy of such a program.

The emergence of the physician-influencer raises new questions on an old debate.

Joan Rubinger overcame a catastrophic biking accident that left her paralyzed to become an influential pain-relief specialist helping top-tier athletes get back on the field after acute and chronic injuries.

What still needs improvement as Manitoba declares a public health emergency?

A recent study found one in three pharmacies in the province could not dispense mifepristone within three days of receiving a prescription.

The province says it will simplify prescription renewals after patients and pharmacists reported problems with the new system.

On June 30, New Brunswick switched to a new private virtual healthcare provider—Foundever—from eVisitNB, another private service that started during the pandemic.